The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of albumin-bound paclitaxel and gemcitabine in patients with newly diagnosed PD-L1 IHC low/unknown stage IV squamous cell lung cancers.
 
Paul K. Paik
Honoraria - ARIAD; Lilly
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb; Celgene; Lilly
Research Funding - Celgene; EMD Serono
Travel, Accommodations, Expenses - EMD Serono
 
Aparajita Srikakulum
No Relationships to Disclose
 
Linda Su Hyun Ahn
No Relationships to Disclose
 
Andrew J. Plodkowski
No Relationships to Disclose
 
Kenneth K. Ng
No Relationships to Disclose
 
Daniel McFarland
No Relationships to Disclose
 
John Joseph Fiore
No Relationships to Disclose
 
Afsheen Iqbal
No Relationships to Disclose
 
Juliana Eng
No Relationships to Disclose
 
Charles M. Rudin
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Harpoon Therapeutics; Seagen